Data-Driven Target Selection
We have one of the strongest track records in AI-driven target discovery and indication expansion as our platform and predictions have contributed to approved drugs and active clinical trials in oncology, Sjogren's disease, Ulcerative Colitis, NASH and epilepsy with 5 different biopharma clients.
Proven, real-world results
"We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general queries."
Tau Benned-Jensen, Senior Research Scientist, H. Lundbeck A/S
This ebook covers the following:
-How computational disease models predict novel gene-disease associations.
-A case study: Target Discovery for Rheumatoid Arthritis
-The benefits of using an AI-integrated knowledge graph for target assessment
Read our Terms and Conditions
We support purchasing via scientist.com and science exchange!